COVID‐19 causes lasting neurological symptoms in some survivors. Like other infections, COVID‐19 may increase risk of cognitive impairment. This perspective highlights four …
L Hardan, D Filtchev, R Kassem, R Bourgi… - Medicina, 2021 - mdpi.com
There are a number of potential implications for the field of Alzheimer's disease (AD) stemming from the global spread of “SARS-COV-2”. Many studies that were conducted by …
Since patients with Alzheimer's disease are at higher risk for hospitalization and death in the setting of COVID-19, additional precautions and protective measures should be put in place …
GA De Erausquin, H Snyder, M Carrillo… - Alzheimer's & …, 2021 - Wiley Online Library
Introduction The increasing evidence of SARS‐CoV‐2 impact on the central nervous system (CNS) raises key questions on its impact for risk of later life cognitive decline, Alzheimer's …
X Xia, Y Wang, J Zheng - Translational Neurodegeneration, 2021 - Springer
Alzheimer's disease (AD) has emerged as a key comorbidity of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …
Introduction Previous studies showed that quarantine for pandemic diseases is associated with several psychological and medical effects. The consequences of quarantine for COVID …
L Wang, PB Davis, ND Volkow… - Journal of …, 2022 - content.iospress.com
An infectious etiology of Alzheimer's disease has been postulated for decades. It remains unknown whether SARS-CoV-2 viral infection is associated with increased risk for …
S Toniolo, M Scarioni, F Di Lorenzo… - Journal of …, 2021 - content.iospress.com
Cognitive impairment following SARS-CoV-2 infection is being increasingly recognized as an acute and possibly also long-term sequela of the disease. Direct viral entry as well as …
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread worldwide and has had …